Norges Bank
KRYS icon

Norges Bank’s Krystal Biotech KRYS Stock Holding History

Norges Bank’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.3M Buy
+259,030
New +$77.4M 0.01% 772
2026
Q1 		– Sell
-284,573
Closed -$70.2M – 746
2025
Q4 		$70.2M Buy
+284,573
New +$59.9M 0.01% 893
2025
Q3 		– Sell
-282,706
Closed -$38.9M – 832
2025
Q2 		$38.9M Buy
282,706
+9,497
+3% +$1.39M ﹤0.01% 1051
2025
Q1 		$49.3M Buy
273,209
+53,681
+24% +$9.03M 0.01% 944
2024
Q4 		$34.4M Sell
219,528
-24,569
-10% -$4.36M ﹤0.01% 1104
2024
Q3 		$44.4M Buy
244,097
+232,757
+2,053% +$44.9M 0.01% 1019
2024
Q2 		$2.08M Hold
11,340
– – ﹤0.01% 1715
2024
Q1 		$2.02M Hold
11,340
– – ﹤0.01% 1736
2023
Q4 		$1.41M Sell
11,340
-6,796
-37% -$754K ﹤0.01% 1829
2023
Q3 		$2.1M Hold
18,136
– – ﹤0.01% 1819
2023
Q2 		$2.13M Sell
18,136
-29,965
-62% -$3.06M ﹤0.01% 1865
2023
Q1 		$3.85M Buy
48,101
+25,018
+108% +$1.97M ﹤0.01% 1825
2022
Q4 		$1.83M Buy
23,083
+9,557
+71% +$709K ﹤0.01% 1982
2022
Q3 		$943K Buy
+13,526
New +$977K ﹤0.01% 2008
2020
Q3 		– Sell
-11,928
Closed -$494K – 2147
2020
Q2 		$494K Buy
11,928
+5,297
+80% +$255K ﹤0.01% 2049
2020
Q1 		$287K Buy
+6,631
New +$347K ﹤0.01% 2032

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank's KRYS Position: Q2 2026 in Review

Norges Bank opened a new position in Krystal Biotech (KRYS) in Q2 2026: 259,030 shares worth $96.3M. The stake represents 0.01% of the portfolio and ranks #772 among its holdings. This is a return to the name: Norges Bank previously reported a position in KRYS as recently as Q4 2025.

Norges Bank first reported a position in KRYS in Q1 2020 and has held it in 16 quarters since. 422 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Norges Bank held 259,030 shares of Krystal Biotech worth $96.3M as of Q2 2026.
  • Krystal Biotech was a new Norges Bank position in Q2 2026.
  • Krystal Biotech made up 0.01% of Norges Bank's portfolio in Q2 2026, its #772 holding.
  • Norges Bank first reported a position in Krystal Biotech in Q1 2020 and has held it in 16 quarters since.
  • 422 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.